The pricing of breakthrough drugs: Theory and policy implications

Keyphrases

• Pharmaceutical Companies 100%
• Generic Drugs 50%
• Drug Costs 50%
• Utility Function 50%
• Pharmaceutical Industry 50%
• Number of Patients 50%
• Marginal Effects 50%
• Consumer Surplus 50%
• Pharmaceutical Sales 50%
• Drug Price Regulation 50%
• Price Regulation 50%
• Patent Protection 50%
• R&D Investment 50%
• Optimal Pricing 50%

Economics, Econometrics and Finance

• Pricing 100%
• Price Regulation 100%
• Wealth 50%
• Utility Function 50%
• Pharmaceutical Industry 50%
• Consumer Surplus 50%